HomeComparePBQQ vs JNJ

PBQQ vs JNJ: Dividend Comparison 2026

PBQQ yields 0.01% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $330.00 in total portfolio value· pulled ahead in Year 7
10 years
PBQQ
PBQQ
● Live price
0.01%
Share price
$28.32
Annual div
$0.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$1.48
Full PBQQ calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PBQQ vs JNJ

📍 JNJ pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPBQQJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PBQQ + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PBQQ pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PBQQ
Annual income on $10K today (after 15% tax)
$1.26/yr
After 10yr DRIP, annual income (after tax)
$1.26/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $702.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PBQQ + JNJ for your $10,000?

PBQQ: 50%JNJ: 50%
100% JNJ50/50100% PBQQ
Portfolio after 10yr
$19.9K
Annual income
$414.63/yr
Blended yield
2.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PBQQ
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PBQQ buys
0
JNJ buys
0
No recent congressional trades found for PBQQ or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPBQQJNJ
Forward yield0.01%3.36%
Annual dividend / share$0.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$19.7K$20.0K
Annual income after 10y$1.48$827.78
Total dividends collected$15.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PBQQ vs JNJ ($10,000, DRIP)

YearPBQQ PortfolioPBQQ Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,701$1.48$10,676$355.77+$25.00PBQQ
2$11,452$1.48$11,407$389.39+$45.00PBQQ
3$12,255$1.48$12,198$426.53+$57.00PBQQ
4$13,115$1.48$13,056$467.62+$59.00PBQQ
5$14,034$1.48$13,987$513.12+$47.00PBQQ
6$15,018$1.48$14,998$563.56+$20.00PBQQ
7← crossover$16,071$1.48$16,098$619.52$27.00JNJ
8$17,197$1.48$17,295$681.69$98.00JNJ
9$18,402$1.48$18,599$750.82$197.00JNJ
10$19,692$1.48$20,022$827.78$330.00JNJ

PBQQ vs JNJ: Complete Analysis 2026

PBQQStock

PBQQ is a basket of defined outcome buffer ETFs. The fund consists of four equity buffer funds, each of which has exposure to QQQs capped gains and 12% buffered losses. The fund will invest equally in the underlying ETFs, holding one ETF with options expiring within three months, a second ETF with options expiring within six months, a third ETF with options expiring within nine months, and a fourth ETF with options expiring within 12 months. Unlike the underlying equity buffer funds that reset annually on a specific month, PBQQ refreshes approximately every 90 days, with one of the underlying ETFs resetting its cap and refreshing its buffer. This creates a continuous hedge for PBQQ regardless of each underlying ETFs outcome period. The approach reduces the timing risks associated with a monthly buffer strategy. Information on the fund exposure to the underlying ETFs and remaining cap and buffer are provided daily on the issuers website.

Full PBQQ Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PBQQ vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PBQQ vs SCHDPBQQ vs JEPIPBQQ vs OPBQQ vs KOPBQQ vs MAINPBQQ vs ABBVPBQQ vs MRKPBQQ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.